COVID-19 in a patient with hypocomplementemic urticarial syndrome and MPO-ANCA vasculitis on hemodialysis treated with omalizumab.
作者信息
Baldallo Cinthia, León Román Juan Carlos, Seron Daniel, Agraz Irene, Solans Roser, Ramos Natalia, Soler María José
机构信息
Servicio de Nefrología, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
Servicio de Nefrología, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain; Grup de Nefrologia, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Spain.
出版信息
Nefrologia (Engl Ed). 2021 May-Jun;41(3):354-355. doi: 10.1016/j.nefroe.2020.07.003. Epub 2021 Jul 21.
Abstract
摘要
相似文献
1
COVID-19 in a patient with hypocomplementemic urticarial syndrome and MPO-ANCA vasculitis on hemodialysis treated with omalizumab.接受奥马珠单抗治疗的低补体血症性荨麻疹综合征和MPO-ANCA血管炎血液透析患者的新型冠状病毒肺炎
Nefrologia (Engl Ed). 2021 May-Jun;41(3):354-355. doi: 10.1016/j.nefroe.2020.07.003. Epub 2021 Jul 21.
2
COVID-19 in a patient with hypocomplementemic urticarial syndrome and MPO-ANCA vasculitis on hemodialysis treated with omalizumab.1例接受奥马珠单抗治疗的血液透析患者合并低补体血症性荨麻疹综合征和MPO-ANCA血管炎并发新型冠状病毒肺炎
Nefrologia (Engl Ed). 2021 May-Jun;41(3):354-356. doi: 10.1016/j.nefro.2020.07.001. Epub 2020 Jul 27.
3
Successful Treatment of Hypocomplementemic Urticarial Vasculitis With Omalizumab: A Case Report.奥马珠单抗成功治疗低补体血症性荨麻疹性血管炎：一例报告
J Investig Allergol Clin Immunol. 2020 Jun;30(3):211-212. doi: 10.18176/jiaci.0486.
4
Omalizumab does not improve skin lesions in a patient with hypocomplementemic urticarial vasculitis syndrome.奥马珠单抗对一名低补体血症性荨麻疹性血管炎综合征患者的皮肤病变无改善作用。
J Eur Acad Dermatol Venereol. 2017 Sep;31(9):e395-e397. doi: 10.1111/jdv.14202. Epub 2017 Mar 29.
5
A Case of Hypocomplementemic Urticarial Vasculitis Syndrome Successfully Treated With Omalizumab.1例使用奥马珠单抗成功治疗的低补体血症性荨麻疹性血管炎综合征病例
J Investig Allergol Clin Immunol. 2017;27(6):382-384. doi: 10.18176/jiaci.0191.
6
Use of omalizumab in the treatment of hypocomplementemic urticarial vasculitis.奥马珠单抗在治疗低补体血症性荨麻疹性血管炎中的应用。
Dermatol Ther. 2020 Mar;33(2):e13237. doi: 10.1111/dth.13237. Epub 2020 Feb 17.
7
Renal transplantation in a patient with hypocomplementemic urticarial vasculitis syndrome.低补体血症性荨麻疹性血管炎综合征患者的肾移植
Am J Kidney Dis. 2001 Jan;37(1):144-148. doi: 10.1016/s0272-6386(01)80068-8.
8
Patient-reported outcomes in urticarial vasculitis treated with omalizumab: case report.奥马珠单抗治疗荨麻疹性血管炎的患者报告结局：病例报告
BMC Dermatol. 2018 Oct 25;18(1):8. doi: 10.1186/s12895-018-0077-x.
9
[Nephropathy associated with hypocomplementemic urticarial vasculitis: A case report and literature review].[低补体血症性荨麻疹性血管炎相关肾病：一例报告及文献复习]
Nephrol Ther. 2020 Mar;16(2):124-135. doi: 10.1016/j.nephro.2019.09.004. Epub 2020 Jan 9.
10
A Case of Crescentic Glomerulonephritis Complicated with Hypocomplementemic Urticarial Vasculitis Syndrome and ANCA-Associated Vasculitis.1例新月体性肾小球肾炎合并低补体血症性荨麻疹性血管炎综合征及抗中性粒细胞胞浆抗体相关性血管炎
Case Rep Nephrol Dial. 2017 Nov 27;7(3):144-153. doi: 10.1159/000484476. eCollection 2017 Sep-Dec.
引用本文的文献
1
Impact of Anti-Type 2 Inflammation Biologic Therapy on COVID-19 Clinical Course and Outcome.抗2型炎症生物疗法对COVID-19临床病程及结局的影响
J Inflamm Res. 2021 Dec 14;14:6845-6853. doi: 10.2147/JIR.S345665. eCollection 2021.
本文引用的文献
1
COVID-19: clinical course and outcomes of 36 hemodialysis patients in Spain.COVID-19：西班牙 36 名血液透析患者的临床病程和转归。
Kidney Int. 2020 Jul;98(1):27-34. doi: 10.1016/j.kint.2020.04.031. Epub 2020 May 11.
2
SARS-CoV-2 infection in patients on renal replacement therapy. Report of the COVID-19 Registry of the Spanish Society of Nephrology (SEN).接受肾脏替代治疗患者的新型冠状病毒2型感染。西班牙肾脏病学会（SEN）COVID-19登记报告。
Nefrologia (Engl Ed). 2020 May-Jun;40(3):272-278. doi: 10.1016/j.nefro.2020.04.002. Epub 2020 Apr 16.
3
Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.意大利伦巴第地区 1591 名 ICU 收治的 SARS-CoV-2 感染患者的基线特征和结局。
JAMA. 2020 Apr 28;323(16):1574-1581. doi: 10.1001/jama.2020.5394.
4
COVID-19 in Hemodialysis Patients: A Report of 5 Cases.COVID-19 于血液透析患者：五例报告。
Am J Kidney Dis. 2020 Jul;76(1):141-143. doi: 10.1053/j.ajkd.2020.03.009. Epub 2020 Mar 31.
5
Chronic kidney disease is associated with severe coronavirus disease 2019 (COVID-19) infection.慢性肾脏病与2019冠状病毒病（COVID-19）严重感染相关。
Int Urol Nephrol. 2020 Jun;52(6):1193-1194. doi: 10.1007/s11255-020-02451-9. Epub 2020 Mar 28.
6
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.中国武汉成人 COVID-19 住院患者的临床病程和死亡危险因素：一项回顾性队列研究。
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
7
Benefits and Harms of Omalizumab Treatment in Adolescent and Adult Patients With Chronic Idiopathic (Spontaneous) Urticaria: A Meta-analysis of "Real-world" Evidence.奥马珠单抗治疗青少年和成人慢性特发性（自发性）荨麻疹患者的获益和危害：“真实世界”证据的荟萃分析。
JAMA Dermatol. 2019 Jan 1;155(1):29-38. doi: 10.1001/jamadermatol.2018.3447.
Zotero 插件